Your browser doesn't support javascript.
loading
BRCA1 mRNA expression and outcome to neoadjuvant cisplatin-based chemotherapy in bladder cancer.
Font, A; Taron, M; Gago, J L; Costa, C; Sánchez, J J; Carrato, C; Mora, M; Celiz, P; Perez, L; Rodríguez, D; Gimenez-Capitan, A; Quiroga, V; Benlloch, S; Ibarz, L; Rosell, R.
Afiliação
  • Font A; Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona. Electronic address: afont@ico.scs.es.
  • Taron M; Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona; Pangaea Biotech, USP Dexeus University Institute, Barcelona.
  • Gago JL; Urology Service, Department of Surgery, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona.
  • Costa C; Pangaea Biotech, USP Dexeus University Institute, Barcelona.
  • Sánchez JJ; Autonomous University of Madrid, Madrid.
  • Carrato C; Pathology Service, Hospital Germans Trias I Pujol, Badalona, Spain.
  • Mora M; Urology Service, Department of Surgery, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona.
  • Celiz P; Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona.
  • Perez L; Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona.
  • Rodríguez D; Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona.
  • Gimenez-Capitan A; Pangaea Biotech, USP Dexeus University Institute, Barcelona.
  • Quiroga V; Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona.
  • Benlloch S; Pangaea Biotech, USP Dexeus University Institute, Barcelona.
  • Ibarz L; Urology Service, Department of Surgery, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona.
  • Rosell R; Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Germans Trias i Pujol and Autonomous University of Barcelona, Badalona; Pangaea Biotech, USP Dexeus University Institute, Barcelona.
Ann Oncol ; 22(1): 139-144, 2011 Jan.
Article em En | MEDLINE | ID: mdl-20603439
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / RNA Mensageiro / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína BRCA1 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2011 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / RNA Mensageiro / Protocolos de Quimioterapia Combinada Antineoplásica / Proteína BRCA1 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2011 Tipo de documento: Article